Information accessed through this web site is presented in summary and interactive form and is not exhaustive. Sunovion Pharmaceuticals Inc. and its U.S. subsidiaries and affiliates make no warranties or representations as to its accuracy or completeness. This information is provided "as is" without warranty of any kind, either express or implied, including but not limited to implied warranties of merchantability, fitness for particular purpose, or non-infringement. Some jurisdictions do not allow exclusion of implied warranties so the above exclusion may not apply to you. Certain links on this site lead to sites or sources located on servers maintained by third parties over which Sunovion has no control. Sunovion makes no representation as to the accuracy or any other aspect of the information contained in or on such sites, sources or servers, nor does Sunovion necessarily endorse such sites or sources. Neither Sunovion nor its affiliates or their respective employees shall be liable in any way for any legal claims, whether in contract, tort or otherwise in any way connected with the use or performance of this web site or any information linked or referenced by this site or any other information or Internet site which link to this site.
The information included in (or accessible from) this web site may contain forward-looking statements that involve risks and uncertainties, including statements with respect to the safety, efficacy, potential benefits, and successful development of the Sunovion's pharmaceuticals under development. Among the factors that could cause actual results to differ materially from those indicated by such forward-looking statements are: the submission, acceptance, and approval of regulatory filings; the results of clinical trials with respect to products under development; the scope of the Sunovion's patent protection with respect to such product candidates; the commercial success of Sunovion's products; the ability of the company to attract and retain qualified personnel; the performance of Sunovion's licensees; the availability of sufficient funds to continue research and development efforts; and certain other factors that may affect future operating results and are detailed in any periodic reports filed with the Securities and Exchange Commission.
Sunovion gives you permission to copy pages of www.lunesta.com documents published herein on the Internet for non-commercial use only, provided any copy of these documents that you make shall retain all copyright and other proprietary notices and any disclaimers contained herein.
All images, trademarks and text are the property of Sunovion and may not be downloaded, distributed, sorted, reused, reported, modified or otherwise used except as provided herein, without the express written permission of Sunovion. All product and service names appearing in a typeface different from that of the surrounding text or with a trademark symbol, including the "Sunovion" logo, are trademarks and service marks owned by Sunovion Pharmaceuticals Inc. or its subsidiaries or affiliates or another company. Use of these marks, except as permitted herein, is expressly prohibited. Nothing contained herein shall be construed as conferring, by implication, estoppel or otherwise, any license or right under any patent or trademark of Sunovion or any third party. Except as expressly provided above, nothing contained herein shall be construed as conferring any license or right under any Sunovion copyright.
No confidential relationship shall be established in the event that any user of this Internet site should make any oral, written or electronic response to Sunovion (such as feedback, questions, comments, suggestions, ideas, etc.). Such response and any information submitted therewith shall be considered non-confidential, and Sunovion shall be free to reproduce, publish or otherwise use such information for any purposes whatsoever including, without limitation, the research, development, manufacture, use or sale of products incorporating such information. The sender of any information to Sunovion is fully responsible for its content, including its truthfulness and accuracy and its non-infringement of any other person's proprietary rights.
IMPORTANT SAFETY INFORMATION
LUNESTA acts quickly, so take it right before bed, and only if you have 8 hours to devote to sleep. Do not take LUNESTA if you are allergic to anything in it. LUNESTA should not be taken together with alcohol. Until you know how you will react to LUNESTA, you should not drive or operate machinery. Call your doctor if your insomnia worsens or is not better within 7 to 10 days. This may mean that there is another condition causing your sleep problems. Walking, eating, driving or engaging in other activities while asleep without remembering it the next day have been reported. Other abnormal behaviors include aggressiveness, agitation, hallucinations and confusion. In depressed patients, worsening of depression including risk of suicide may occur. These risks may increase if you drink alcohol. Severe allergic reactions such as swelling of the tongue and throat occur rarely and may be fatal. Call your doctor if you experience these or any effects or reactions that concern you. LUNESTA, like most sleep medicines, carries some risk of dependency. Side effects may include unpleasant taste, headache, morning drowsiness and dizziness.
Lunesta® (eszopiclone) is a prescription sleep medicine used in adults for the treatment of a sleep problem called insomnia. Symptoms of insomnia include trouble falling asleep and waking up often during the night.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. For more information, please see the LUNESTA Medication Guide and Full Prescribing Information.